Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03214510 · ClinicalTrials.gov registry record · Phase 3

Thoracic Epidural Analgesia or Four-Quadrant Transversus Abdominus Plane Block in Reducing Pain in Patients Undergoing Liver Surgery

A Phase 3 study of Liver and Intrahepatic Bile Duct Disorder, sponsored by M.D. Anderson Cancer Center.

Active
Registry status
Phase 3
Development phase
101
Enrollment target
1
Study location

NCT03214510 is a Phase 3 study of Liver and Intrahepatic Bile Duct Disorder that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 101 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03214510, a Phase 3 study of Liver and Intrahepatic Bile Duct Disorder, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.

ACTIVE NOT RECRUITING
Registry status
Phase 3
Development phase
101 participants
Enrollment target
1
Study location

Study Summary

This phase III trial studies how well thoracic epidural analgesia or four-quadrant transversus abdominus plane block works in reducing pain in patients undergoing liver surgery. It is not yet known whether thoracic epidural analgesia or four-quadrant transversus abdominus plane block may help people to recover more completely and more quickly after surgery.

Interventions

  • DRUG Bupivacaine
  • DRUG Fentanyl
  • DEVICE Implanted Medical Device
  • DRUG Hydromorphone Hydrochloride

Study Locations (1)

Texas

  • M D Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 101 participants
Start Date 2017-10-04
Est. Completion 2026-07-31
Phase Phase 3

Sponsor

M.D. Anderson Cancer Center

2,692 total trials

What the Registry Record Tells You About NCT03214510

The ClinicalTrials.gov registry entry for NCT03214510 describes a study currently listed as active not recruiting, categorized as Phase 3. The registered enrollment target is 101 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Liver and Intrahepatic Bile Duct Disorder appearing as the primary indexed condition, and to 4 interventions - of which Bupivacaine is the first listed.

NCT03214510 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT03214510 about?

NCT03214510 is a clinical study titled "Thoracic Epidural Analgesia or Four-Quadrant Transversus Abdominus Plane Block in Reducing Pain in Patients Undergoing Liver Surgery". This phase III trial studies how well thoracic epidural analgesia or four-quadrant transversus abdominus plane block works in reducing pain in patients undergoing liver surgery. It is not yet known whether thoracic epidural analgesia or four-quadrant transversus abdominus plane block may help people...

What is the current status of trial NCT03214510?

This trial is currently active not recruiting. It is a Phase 3 study. The enrollment target is 101 participants. The study started on 2017-10-04. Estimated completion is 2026-07-31.

What conditions does trial NCT03214510 study?

This clinical trial studies the following conditions: Liver and Intrahepatic Bile Duct Disorder.

What interventions are being tested in trial NCT03214510?

The interventions under investigation include: Bupivacaine (DRUG), Fentanyl (DRUG), Implanted Medical Device (DEVICE), Hydromorphone Hydrochloride (DRUG).

Who is sponsoring clinical trial NCT03214510?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03214510 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Liver and Intrahepatic Bile Duct Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.